These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17386181)

  • 1. Relevance of nitric oxide for myocardial remodeling.
    Massion PB; Balligand JL
    Curr Heart Fail Rep; 2007 Mar; 4(1):18-25. PubMed ID: 17386181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous myocardial infarction and nitric oxide synthase.
    Tsutsui M; Nakata S; Shimokawa H; Otsuji Y; Yanagihara N
    Trends Cardiovasc Med; 2008 Nov; 18(8):275-9. PubMed ID: 19345314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H; Kästner S; Strobel A; Studer R; Brodde OE; Hasenfuss G
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the three nitric oxide synthase isoforms and nitric oxide level in the rat heart during cold storage and blood reperfusion.
    Desrois M; Caus T; Dalmasso C; Lan C; Cozzone PJ; Bernard M
    Cell Mol Biol (Noisy-le-grand); 2009 Dec; 55 Suppl():OL1208-14. PubMed ID: 20018145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
    Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
    Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive nitric oxide synthases in the heart from hypertrophy to failure.
    Loyer X; Heymes C; Samuel JL
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):483-8. PubMed ID: 18307746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase.
    Niu X; Watts VL; Cingolani OH; Sivakumaran V; Leyton-Mange JS; Ellis CL; Miller KL; Vandegaer K; Bedja D; Gabrielson KL; Paolocci N; Kass DA; Barouch LA
    J Am Coll Cardiol; 2012 May; 59(22):1979-87. PubMed ID: 22624839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential.
    Roy R; Wilcox J; Webb AJ; O'Gallagher K
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous endothelium-derived nitric oxide inhibits myocardial caspase activity: implications for treatment of end-stage heart failure.
    Mital S; Barbone A; Addonizio LJ; Quaegebeur JM; Mosca RJ; Oz MC; Hintze TH
    J Heart Lung Transplant; 2002 May; 21(5):576-85. PubMed ID: 11983548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
    Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
    Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting NOS as a therapeutic approach for heart failure.
    Tang L; Wang H; Ziolo MT
    Pharmacol Ther; 2014 Jun; 142(3):306-15. PubMed ID: 24380841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual modulation of nitric oxide production in the heart during ischaemia/reperfusion injury and inflammation.
    Darra E; Rungatscher A; Carcereri de Prati A; Podesser BK; Faggian G; Scarabelli T; Mazzucco A; Hallström S; Suzuki H
    Thromb Haemost; 2010 Aug; 104(2):200-6. PubMed ID: 20508903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.
    Gealekman O; Abassi Z; Rubinstein I; Winaver J; Binah O
    Circulation; 2002 Jan; 105(2):236-43. PubMed ID: 11790707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Brunner F; Andrew P; Wölkart G; Zechner R; Mayer B
    Circulation; 2001 Dec; 104(25):3097-102. PubMed ID: 11748107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart.
    Umar S; van der Laarse A
    Mol Cell Biochem; 2010 Jan; 333(1-2):191-201. PubMed ID: 19618122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation.
    Gao F; Gao E; Yue TL; Ohlstein EH; Lopez BL; Christopher TA; Ma XL
    Circulation; 2002 Mar; 105(12):1497-502. PubMed ID: 11914261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.
    Prabhu SD; Chandrasekar B; Murray DR; Freeman GL
    Circulation; 2000 May; 101(17):2103-9. PubMed ID: 10790354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.